388
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Investigation into physical–chemical variables affecting the manufacture and dissolution of wet-milled clarithromycin nanoparticles

, , , &
Pages 911-921 | Received 26 Feb 2013, Accepted 21 Aug 2013, Published online: 04 Oct 2013

References

  • Junghanns J-UAH, Mueller RH. Nanocrystal technology, drug delivery and clinical applications. Int J Nanomed 2008;3:295–309
  • Noyes A, Whitney WR. The rate of solution of solid substances in their own solutions. J Am Chem Soc 1897;19:930–934
  • Van Eerdenbrugh B, Van den Mooter G, Augustijns P. Top-down production of drug nanocrystals: nanosuspension stabilization, miniaturization and transformation into solid products. Int J Pharm 2008;364:64–75
  • Liu P, Rong X, Laru J, et al. Nanosuspensions of poorly soluble drugs: preparation and development by wet milling. Int J Pharm 2011;411:215–222
  • Peltonen L, Hirvonen J. Pharmaceutical nanocrystals by nanomilling: critical process parameters, particle fracturing and stabilization methods. J Pharm Pharmacol 2010;62:1569–1579
  • de Waard H, Frijlink HW, Hinrichs WLJ. Bottom-up preparation techniques for nanocrystals of lipophilic drugs. Pharm Res 2011;28:1220–1223
  • Grubel P, Cave DR. Factors affecting solubility and penetration of clarithromycin through gastric mucus. Aliment Pharmacol Ther 1998;12:569–576
  • Hardy DJ, Guay DRP, Jones RN. Clarithromycin, a unique macrolide – a pharmacokinetic, microbiological, and clinical review. Diagn Microbiol Infect Dis 1992;15:39–53
  • Piscitelli SC, Danziger LH, Rodvold KA. Clarithromycin and azithromycin – new macrolide antibiotics. Clin Pharm 1992;11:137–152
  • LingHao Q, Wei L. Formulation and evaluation of less-painful clarithromycin lipid microspheres. Arch Pharm Res 2007;30:1336–1343
  • Traini D, Young PM. Delivery of antibiotics to the respiratory tract: an update. Expert Opin Drug Del 2009;6:897–905
  • Turner S, Ravishankar J, Fassihi R, inventors. Method for improving the bioavailability of orally delivered therapeutics. United State Patent Application, US20060068010 A1, Mar 30, 2006
  • Salem, II, Duzgunes N. Efficacies of cyclodextrin-complexed and liposome-encapsulated clarithromycin against Mycobacterium avium complex infection in human macrophages. Int J Pharm 2003;250:403–414
  • Inoue Y, Yoshimura S, Tozuka Y, et al. Application of ascorbic acid 2-glucoside as a solubilizing agent for clarithromycin: solubilization and nanoparticle formation. Int J Pharm 2007;331:38–45
  • Yonemochi E, Kitahara S, Maeda S, et al. Physicochemical properties of amorphous clarithromycin obtained by grinding and spray drying. Eur J Pharm Sci 1999;7:331–338
  • Torchilin VP. Nanoparticulates as drug carriers. London: Imperial College Press; 2006
  • Singh-Joy SD, McLain VC. Safety assessment of poloxamers 101, 105, 108, 122, 123, 124, 181, 182, 183, 184, 185, 188, 212, 215, 217, 231, 234, 235, 237, 238, 282, 284, 288, 331, 333, 334, 335, 338, 401, 402, 403, and 407, poloxamer 105 benzoate, and poloxamer 182 dibenzoate as used in cosmetics. Int J Toxicol 2008;27:93–128
  • Liang HJ, Yang QX, Deng L, et al. Phospholipid-Tween 80 mixed micelles as an intravenous delivery carrier for paclitaxel. Drug Dev Ind Pharm 2011;37:597–605
  • Kronberg B, Dahlman A, Carlfors J, et al. Preparation and evaluation of sterically stabilized liposomes – colloidal stability, serum stability, macrophage uptake, and toxicity. J Pharm Sci 1990;79:667–671
  • Chen Y, Yang HW. Hydroxypropyl cellulose (Hpc)-stabilized dispersion polymerization of styrene in polar-solvents – effect of reaction parameters. J Polym Sci Polym Chem 1992;30:2765–2772
  • Hong J, Hong CK, Shim SE. Synthesis of polystyrene microspheres by dispersion polymerization using poly(vinyl alcohol) as a steric stabilizer in aqueous alcohol media. Colloid Surf A 2007;302:225–233
  • Liu Y, Tong Z, Prud'homme RK. Stabilized polymeric nanoparticles for controlled and efficient release of bifenthrin. Pest Manag Sci 2008;64:808–812
  • Vergnault G, Grenier P, Nhamias A, inventors. Spironolactone nanoparticles, compositions and methods related thereto. United State Patent Application, US20080069886 A1, Mar 20, 2008
  • Kumar MP, Rao YM, Apte S. Formulation of nanosuspensions of albendazole for oral administration. Curr Nanosci 2008;4:53–58
  • Ecevit B, Afolawemi A. A combined microhydrodynamics-polymer adsorption analysis for elucidation of the roles of stabilizers in wet stirred media milling. Int J Pharm 2012;439:193–206
  • Cerdeira AM, Mazzotti M, Gander B. Miconazole nanosuspensions: influence of formulation variables on particle size reduction and physical stability. Int J Pharm 2010;396:210–218
  • Lee J, Choi JY, Park CH. Characteristics of polymers enabling nano-comminution of water-insoluble drugs. Int J Pharm 2008;355:328–336
  • Brodka-Pfeiffer K, Langguth P, Grass P, Hausler H. Influence of mechanical activation on the physical stability of salbutamol sulphate. Eur J Pharm Biopharm 2003;56:393–400
  • Sepassi S, Goodwin DJ, Drake AF, et al. Effect of polymer molecular weight on the production of drug nanoparticles. J Pharm Sci 2007;96:2655–2666
  • Kumar N, Salman M, Gangakhedkar KK, inventors. Novel amorphous form of clarithromycin. World Intellectual Property Organization Patent Application, WO2000077017 A1, Dec 21, 2000
  • Westedt U, Rosenberg J, Knobloch M, et al. inventors. Preparation of compositions with essentially noncrystalline embedded macrolide antibiotics. United State Patent, US8337733 B2, Dec 25, 2012
  • Deng Z, Xu S, Li S. Understanding a relaxation behavior in a nanoparticle suspension for drug delivery applications. Int J Pharm 2008;351:236–243
  • Tozuka Y, Ito A, Seki H, et al. Characterization and quantitation of clarithromycin polymorphs by powder X-ray diffractometry and solid-state NMR spectroscopy. Chem Pharm Bull 2002;50:1128–1130
  • Chokshi RJ, Sandhu HK, Iyer RM, et al. Characterization of physico-mechanical properties of indomethacin and polymers to assess their suitability for hot-melt extrusion processs as a means to manufacture solid dispersion/solution. J Pharm Sci 2005;94:2463–2474
  • Hecq J, Deleers M, Fanara D, et al. Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine. Int J Pharm 2005;299:167–177
  • Dolenc A, Kristl J, Baumgartner S, Planinsek O. Advantages of celecoxib nanosuspension formulation and transformation into tablets. Int J Pharm 2009;376:204–212
  • Mashru RC, Sutariya VB, Sankalia MG, Yagnakumar P. Characterization of solid dispersions of rofecoxib using differential scanning calorimeter. J Therm Anal Calorim 2005;82:167–170
  • Strawhecker KE, Manias E. Structure and properties of poly(vinyl alcohol)/Na+ montmorillonite nanocomposites. Chem Mater 2000;12:2943–2949
  • Tita B, Fulias A, Bandur G, et al. Compatibility study between ketoprofen and pharmaceutical excipients used in solid dosage forms. J Pharma Biomed 2011;56:221–227
  • Thomas J, Lowman A, Marcolongo M. Novel associated hydrogels for nucleus pulposus replacement. J Biomed Mater Res A 2003;67A:1329–1337
  • Chakraborty S, Shukla D, Jain A, et al. Assessment of solubilization characteristics of different surfactants for carvedilol phosphate as a function of pH. J Colloid Interf Sci 2009;335:242–249
  • Khan KA. The concept of dissolution efficiency. J Pharm Pharmacol 1975;27:48–49
  • Heng D, Cutler DJ, Chan H-K, et al. What is a suitable dissolution method for drug nanoparticles? Pharm Res 2008;25:1696–1701

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.